» Articles » PMID: 39030227

Causality Between Six Psychiatric Disorders and Digestive Tract Cancers Risk: a Two-sample Mendelian Randomization Study

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jul 19
PMID 39030227
Authors
Affiliations
Soon will be listed here.
Abstract

Associations between psychiatric disorders and digestive tract cancers have been proposed. However, the causal link between these factors remains unclear. This study pioneers Mendelian randomization (MR) analysis to explore the genetic link between psychiatric disorders and digestive tract cancers risk. We analysed data on six psychiatric disorders [schizophrenia, bipolar disorder, major depressive disorder (MDD), attention deficit hyperactivity disorder, autism spectrum disorder, and panic disorder (PD)] and digestive tract cancers [esophagus cancer (EC), gastric cancer (GC), and colorectal cancer (CRC)] from genome-wide association studies databases. Using instrumental variables identified from significant single nucleotide polymorphism associations, we employed the inverse variance weighted (IVW) method alongside the weighted median (WM) method and MR-Egger regression. The results revealed no causal link between psychiatric disorders and the risk of EC or GC. Psychiatric disorders were not identified as risk factors for CRC. Notably, PD demonstrated a lower CRC risk (OR = 0.79, 95% CI 0.66-0.93, P = 0.01). This MR analysis underscores the lack of a causal association between psychiatric disorders and digestive tract cancers risk while suggesting a potential protective effect of PD against CRC.

Citing Articles

The Importance of Genetic Screening on the Syndromes of Colorectal Cancer and Gastric Cancer: A 2024 Update.

Lupan I, Silaghi C, Stroe C, Muntean A, Deleanu D, Bintintan V Biomedicines. 2025; 12(12.

PMID: 39767561 PMC: 11674014. DOI: 10.3390/biomedicines12122655.

References
1.
Forstner A, Awasthi S, Wolf C, Maron E, Erhardt A, Czamara D . Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression. Mol Psychiatry. 2019; 26(8):4179-4190. DOI: 10.1038/s41380-019-0590-2. View

2.
Cohen M, Dembling B, Schorling J . The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res. 2002; 57(2-3):139-46. DOI: 10.1016/s0920-9964(01)00308-5. View

3.
Solmi M, Firth J, Miola A, Fornaro M, Frison E, Fusar-Poli P . Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people. Lancet Psychiatry. 2019; 7(1):52-63. DOI: 10.1016/S2215-0366(19)30414-6. View

4.
Gulbinat W, Dupont A, Jablensky A, JENSEN O, Marsella A, Nakane Y . Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br J Psychiatry Suppl. 1992; (18):75-83. View

5.
Chien W, Sun Q, Lee K, Ding L, Wuensche P, Torres-Fernandez L . Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer. Mol Oncol. 2015; 9(4):889-905. PMC: 4387089. DOI: 10.1016/j.molonc.2015.01.002. View